Dapaglyn SM 100/500 Tablet ER
Marketer
Zydus Healthcare Limited
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg) + Sitagliptin (100mg)
Overview Dapaglyn SM 100/500 Tablet ER
For adults with type 2 diabetes, the extended-release combination medication Dapaglyn SM 100/500mg assists in regulating blood glucose. This medication complements diet and exercise to enhance blood sugar management, facilitating improved insulin use and subsequent blood sugar reduction. Dapaglyn SM 100/500mg can be administered with or without food, though consistent daily timing is recommended. Dosage is determined by your physician; discontinuation requires their consultation, as abrupt cessation may elevate blood sugar, risking serious complications such as renal impairment or vision loss. This medication forms part of a broader treatment plan encompassing a healthy diet, regular physical activity, and weight management, as directed by your doctor. Common adverse effects may include upper respiratory tract infections, nasal congestion, sore throat, and urinary tract infections. Adequate hydration is crucial to minimize dehydration. Genital yeast infections are a potential side effect; diligent hygiene can help mitigate this risk. Prior to commencing Dapaglyn SM 100/500mg, patients with kidney or liver disease, urinary tract infections, or those using diuretics should inform their doctor. Pregnant or lactating individuals require medical consultation before use. Excessive alcohol consumption should be avoided as it may exacerbate side effects. Regular blood glucose monitoring is essential while using this medication.
Primary Ingredients of Dapaglyn SM 100/500 Tablet ER
No text provided to rephrase.
Uses of Dapaglyn SM 100/500 Tablet ER
Managing type 2 diabetes
Major Benefits of Dapaglyn SM 100/500 Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapaglyn SM 100/500 Tablet ER can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Dapaglyn SM 100/500 Tablet ER:
- Diarrhea
- Nausea
- Vomiting
- Flatulence
- Polyuria
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Hypoglycemia (low blood glucose level)
- Cough
How to use Dapaglyn SM 100/500 Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapaglyn SM 100/500 Extended-Release tablets may be consumed with or without food, although consistent timing is recommended.
How Dapaglyn SM 100/500 Tablet ER works:
Dapaglyn SM 100/500 Extended-Release tablets combine three antidiabetic agents to manage blood sugar. Dapagliflozin enhances glucose elimination via urine, lowering blood glucose. Metformin reduces glucose absorption from ingested food and hepatic glucose production. Furthermore, metformin improves insulin sensitivity, boosting the body's natural glucose regulation. Sitagliptin regulates blood sugar by stimulating incretin production, prompting the pancreas to release more insulin and suppressing excess hepatic glucose output.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Dapaglyn SM 100/500 Tablet ER has unknown safety implications. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Dapagliflozin/Metformin extended-release tablets (100/500 mg) in pregnancy is currently lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Dapaglyn SM 100/500 Extended-Release tablets while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Extended-release Dapaglyn SM 100/500 tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Dapagliflozin/Metformin extended-release tablets (100/500 mg) in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Dapagliflozin/Metformin extended-release tablets (100/500 mg) in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Dapaglyn SM 100/500 Tablet ER :
Should you forget a Dapaglyn SM 100/500 Tablet ER dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapaglyn SM 100/500 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |

